The alternative (“alt-“) animal products industry is growing increasingly more popular each year, causing an increased demand in foods made
Continue Reading Foodtech Patents: Who’s on the Board and What Moves are they Making?
Keeping Your Federally-Funded Inventions: Requirements to Comply with the Bayh-Dole Act
Federal funding is a huge boon for companies, universities, and research institutions conducting innovative research. However, it comes attached with
Continue Reading Keeping Your Federally-Funded Inventions: Requirements to Comply with the Bayh-Dole Act
The Evolving Gene Editing Landscape: From Research Tool to Market
Gene therapies have been the subject of tremendous scientific research and investment. With hundreds of clinical trials in progress and
Continue Reading The Evolving Gene Editing Landscape: From Research Tool to Market
Patent Invalid Due to Trade Show Demonstration More Than One Year Before Filing Date
In a cautionary tale for inventors participating in trade shows and other non-confidential presentations, on February 15, 2023, the U.S.
Continue Reading Patent Invalid Due to Trade Show Demonstration More Than One Year Before Filing Date
mRNA IP 2022 Year in Review: Pioneers Clash in Major Patent Litigations
Substantial patent litigation activity occurred in the mRNA space in 2022, involving nearly all of the major mRNA and lipid
Continue Reading mRNA IP 2022 Year in Review: Pioneers Clash in Major Patent Litigations
Upcycling: A Question of Law and Optics
Great buzz resulted from the World Bank study showing that the fashion industry is responsible for about 10% of annual
Continue Reading Upcycling: A Question of Law and Optics
Fashion Meets Web3 – Protecting Emerging Phygital Fashion Innovations
Web3, the up-and-coming decentralized iteration of the World Wide Web built on the blockchain, presents a unique opportunity for fashion
Continue Reading Fashion Meets Web3 – Protecting Emerging Phygital Fashion Innovations
Will Divergent Copyright Laws Between the US and UK Influence Where You Do Business as an Artificial Intelligence Company?
Spurred by the vast potential of artificial intelligence (AI) and machine learning (ML) technologies, many countries are evaluating whether existing
Continue Reading Will Divergent Copyright Laws Between the US and UK Influence Where You Do Business as an Artificial Intelligence Company?
The Current mRNA/LNP Patent Litigation Landscape
Several patent litigations have been filed involving mRNA pioneers such as Moderna, Inc. and BioNTech, Inc. (with Pfizer) over the
Continue Reading The Current mRNA/LNP Patent Litigation Landscape
Merck and Orna Therapeutics Join Forces in Circular RNA Collaboration
On August 16, 2022, Merck (NYSE: MRK) and Orna Therapeutics each announced that they entered into a collaboration agreement relating
Continue Reading Merck and Orna Therapeutics Join Forces in Circular RNA Collaboration